Abaxx runs a rare Singapore-licensed commodity-futures exchange for LNG, carbon, metals and silver — a genuinely hard licence to hold. But it is loss-making and pre-profit, and an unproven short-seller allegation plus an undated regulatory review keep the outcome binary. The stock is 59% off its May high. So the call is HOLD, under review, on every horizon: bear C$14, bull C$55.
Re-presenting the Donatien Investment report on Abaxx Technologies (TSX:ABXX), dated 4 August 2026, at C$27.56. HOLD on the short, medium and long horizons — a low-confidence name under review, dominated by a binary event.
Abaxx builds and operates a regulated commodity-futures exchange and clearing house, licensed by the Monetary Authority of Singapore, trading physically-settled contracts for L-N-G, carbon, battery metals and silver. That licence is genuinely rare and hard to stand up. And the traction is accelerating: second-quarter volume reached eight hundred and eighty-eight thousand contracts, up two hundred and seventy-six per cent on the prior quarter, with year-to-date volume up six hundred per cent. It also completed its first multi-party carbon futures delivery in July — a physical settlement, which is much harder to fake than screen volume. Business quality is a middling fifty-seven: a real asset, still sub-scale.

Now the reason this is only a hold. A short-seller, Viceroy Research, alleges that much of Abaxx's reported volume is wash or incentivised trading rather than genuine liquidity. Abaxx categorically denies it, has engaged the law firm Paul Weiss, and has asked regulators to review the trading. These allegations are unproven and unadjudicated — we treat them as a live risk, not as fact, because scoring an unproven short report as truth would be adopting its book. Reviews sit with regulators in Canada and Singapore, undated. On top of that the valuation is rich — around three hundred and sixty times trailing revenue — and the company is still loss-making with under two years of cash runway.

So the honest call is hold, under review, on every horizon — and to be plain about how wide the range is. If the review clears Abaxx and the volume ramp proves genuine, the credibility overhang lifts and the stock can re-rate: that is the fifty-five-dollar bull case, a one-in-four chance. If instead a regulatory finding substantiates that activity was manipulated, the liquidity thesis weakens and dilution deepens at distressed prices: that is the fourteen-dollar bear case, also one-in-four. The middle, most-likely path is a range-trade in the mid-twenties to mid-thirties while the dispute drags on — base thirty dollars. Those tails roughly offset, which is exactly why it is a hold, not a directional bet. The next real check is second-quarter results on the seventeenth of August.

Binary regulatory review — outcome unknown, undated. Unproven wash-trade allegation over core metric. Loss-making, pre-profit; dilution risk. Bear C$14 (−49%) if allegations substantiated.

Against the current C$27.56, the report frames a bull case at C$55 (+100%), a base case at C$30 (+9%) and a bear case at C$14 (-49%). See the full report for the probability weight behind each path.
Abaxx runs a rare Singapore-licensed commodity-futures exchange for LNG, carbon, metals and silver — a genuinely hard licence to hold. But it is loss-making and pre-profit, and an unproven short-seller allegation plus an undated regulatory review keep the outcome binary. The stock is 59% off its May high. So the call is HOLD, under review, on every horizon: bear C$14, bull C$55.
Read the full report on donatien.ca →